DEBRA Austria | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

966 results for “DEBRA Austria”

Trials

View all 253 →

Infant Nutrition in Austria

1,666 participants · First posted Oct 24, 2019

Metastatic Breast Cancer in Austria

5,000 participants · First posted Mar 12, 2019

Outpatient Cardiac Rehabilitation in Austria

1,200 participants · First posted Feb 28, 2012

Drugs

View all 25 →

Influenza B virus B/Austria/1359417/2021 live (attenuated) antigen(FluMist Quadrivalent)

VLA-1701

Influenza B virus B/Austria/1359417/2021 BVR-26 hemagglutinin antigen (formaldehyde inactivated)(Fluad Quadrivalent, Fluarix Quadrivalent)

Organizations

View all 373 →

Valneva Austria GmbH

Austria

Takeda Austria GmbH

Austria

Roche Austria GmbH

Austria

News

View all 315 →

RHEACELL and AOP Health Partner to Advance Stem Cell Therapy for Epidermolysis Bullosa and Chronic Venous Wounds

DEBRA Research and Nonsense Therapeutics Form ReadOn Therapeutics to Advance Epidermolysis Bullosa Treatments

CureDuchenne Ventures Drives Duchenne Muscular Dystrophy Research with $26 Million Investment

Page 1 of 97